BioLineRx (BLRX) Profit After Tax: 2023-2025
Historic Profit After Tax for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to -$1.4 million.
- BioLineRx's Profit After Tax changed negligibly% to -$1.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$3.5 million, marking a year-over-year increase of 81.96%. This contributed to the annual value of -$9.2 million for FY2024, which is 84.79% up from last year.
- Per BioLineRx's latest filing, its Profit After Tax stood at -$1.4 million for Q2 2025, which was down 127.62% from $5.1 million recorded in Q1 2025.
- BioLineRx's 5-year Profit After Tax high stood at $18.5 million for Q2 2023, and its period low was -$16.0 million during Q3 2023.
- Moreover, its 3-year median value for Profit After Tax was -$1.4 million (2025), whereas its average is -$1.7 million.
- As far as peak fluctuations go, BioLineRx's Profit After Tax tumbled by 107.64% in 2024, and later surged by 836.64% in 2025.
- Quarterly analysis of 3 years shows BioLineRx's Profit After Tax stood at -$1.4 million in 2023, then remained steady at -$1.4 million in 2024, then remained steady at -$1.4 million in 2025.
- Its last three reported values are -$1.4 million in Q2 2025, $5.1 million for Q1 2025, and -$1.4 million during Q4 2024.